Abstrak
Metabolic syndrome (MetS) is clinically defi ned as collective cardio-vascular disease (CVD) risks that include central obesity, dyslipidemia, hyperglycemia and hypertension. This syndrome is well documented to contribute to the development of CVD, type 2 diabetes and other related degenerative diseases like non-alcoholic steato-hepatitis (NASH), polycystic ovary syndrome (PCOS), and cancer. MetS is a growing health problem in developed and developing countries, including Indonesia. Data from the Indonesian Society for the Study of Obesity (ISSO) showed that the prevalence of MetS, using the criteria recommended by the National Cholesterol Education Program (NCEP)-Adult Treatment Program (ATP) III, was ≈ 24% of 3429 adult people studied. [1] [2] [3] [4] [5] Central obesity is a major component of MetS events, but the underlying mechanism of metabolic problems in MetS is not fully understood. Apart from being as a fat storage, adipose tissue has been considered as an organ that produces active biological molecules (adipokine), proinfl ammatory cytokines, anti-infl ammatory hormones and other biological substances. It is evidence that obesity contributes to increased expression of proinfl ammatory cytokines in the blood circulation, which then leads to infl ammation of the vascular wall. 1, 3, 5, 6 Furthermore, obesity is strongly associated with increased lipid metabolism. In individuals with MetS, production of reactive oxygen species (ROS) is elevated in both circulation and adipocytes. Increased production of ROS in adipocytes contributes to the interruption of the oxidation-reduction (redox) reaction, which, in turn, leads to the decline of anti-oxidative enzymes in the blood circulation. This condition is known as oxidative stress, which plays important roles in the pathogenesis of many degenerative diseases. High oxidative stress leads to disorder of metabolism in adipose tissue, which constitutes an early pathway to MetS, hypertension and coronary atherosclerosis. There is also compelling evidence that in individuals with MetS, the occurrence of endothelial dysfunction and intima media thickening of the vascular wall was consistent with elevated levels of C-reactive protein (CRP) and adhesion molecules in plasma. CRP production is induced by interleukin-6 (IL-6) and regulated by tumor necrosis factor (TNF-α). CRP has the potential to recruit low-density lipoprotein (LDL) through the induction of cytokines to express proinfl ammatory process. High levels of CRP and adhesion molecules contribute to endothelial dysfunction and intima-media thickening of the vascular wall. [6] [7] [8] The abovementioned underlying background has provided inspiration to further explore the patho-biologic mechanism of infl ammation, and its interplays with oxidative stress and endothelial dysfunction in individuals with MetS, especially those with central obesity, in line with the common soil hypothesis. Furthermore, available studies on the links between infl ammation, oxidative stress and endothelial dysfunction (vascular disease triads) 9 in Indonesian individuals are very limited, albeit coinciding with the prevailing MetS in Indonesia.
2 These conditions justifi ed the need to undertake the current study. In this study, biochemical parameters with signifi cant correlation for determining risks of MetS prior to the development of vascular diseases were used.
METHODS

Study Design
The design of this study was case control, comparing adiponectin, hsCRP, TAOS, and various metabolic profi les between normal (non-MetS) subjects as control and subjects with MetS as case. 
Subjects
Subjects were recruited from Prodia Clinical Laboratory in Jakarta for general medical check-up, employees and relatives of Prodia Clinical Laboratory in Jakarta. Subjects who were apparently healthy, male, aged 40-60 years old and willing to follow the study protocol, were considered eligible to be included in the study.
Subjects who were consuming steroids; or had consumed antioxidant supplements such as vitamins C and or E, green tea or other supplements known as antioxidants for the last 3 weeks; or had been treated with anti-infl ammatory drugs such as statins or tiazolidinedione for the last 3 weeks; or had liver dysfunction, kidney dysfunction, asthma, fever, were excluded from the study.
Sample size calculation was based on the difference in the value of serum hsCRP and adiponectin concentrations between non-MetS and MetS subjects. The power and level of signifi cance were defi ned at 80% and 5%, respectively. Based on the study by Xydakis et al, 10 16 subjects in each group were required to detect 2 mg/L difference in serum hsCRP concentration. In a similar way, 25 subjects in each group were required to detect 3 ng/mL difference in serum adiponectin concentration. Therefore, a total of 72 subjects, consisting of 36 nonMetS and 36 MetS subjects, were considered adequate in the present study.
Subjects in the MetS category met the International Diabetes Federation (IDF) criteria for MetS, 11 they were central obesity [waist circumference (WC) ≥ 90 cm] with two of the other four clinical indicators: triglycerides ≥ 150 mg/dL, HDL-C <40 mg/dL, systolic blood pressure (SBP) ≥ 130 or diastolic blood pressure (DBP) ≥ 85 mm Hg, fasting blood glucose (FBG) ≥ 100 mg/dL. Each subject was provided with explanation about the study, and signed informed consent prior to the commencement of the study.
Anthropometric Measurement
Body weight (BW) was measured in kilograms to the nearest 0.1 kg, with light clothes on, using a beam scale Tanita (Tanita, Japan). Height (Ht) was measured in centimeters to the nearest 0.1 cm, in standing position with socks and shoes removed, using a microtois (stature meter). Waist circumference was measured in centimeters to the nearest 0.1 cm, using a fl exible non-elastic tape made by Roche (Roche, Switzerland). Waist circumference was measured at the midway region between the lowest rib margin and the iliac crest, in standing position with abdomen relaxed, feet together and weight equally divided over both legs. Body mass index (BMI) was calculated by dividing body weight in kg by height in squared meter.
Blood Pressure Measurement
Blood pressure was measured using a sphygmomanometer during the course of the study. Subjects were seated for at least 5 min before the actual measurement was taken. The fi rst Korotkoff sound represented systolic blood pressure and the fi fth Korotkoff sound (when sound just disappears) was taken as the diastolic blood pressure. Two measurements were taken with a 5 min interval, and the average value was used.
Biochemical Assessment
Fasting blood samples were collected in the morning between 07:00 to 10:00 am. Plasma and serum were separated immediately by centrifugation and aliquots were frozen at -20 0 C for subsequent batched analysis for adiponectin and high-sensitivity C-reactive protein (hsCRP). Total anti-oxidant status (TAOS) and biochemical laboratory test were determined immediately soon after the separation process.
Serum TAOS, triglycerides, total cholesterol (TC), low and high-density lipoprotein cholesterol (LDL-C and HDL -C), FBG, creatinine, alanine amino transferase (ALT) and aspartate amino transferase (AST) levels were assayed by the Prodia Clinical Laboratory's routine chemistry procedures. Serum AST, ALT and creatinine were determined using the International Federation of Clinical Chemistry (IFCC) method and reagents manufactured by Roche (Mannheim, Germany). The Standard automated glucose oxidase method was used to determined glucose, reagents manufactured by Roche (Mannheim, Germany). Homogeneous method was used to determine HDL-C, using reagents manufactured by Daiichi ® Tokyo-Japan. The phosphate glycerol oxidaseperoxidase anti-peroxidase (GPO-PAP) method was used to determine triglycerides, using reagent manufactured by Roche (Mannheim, Germany).
Fasting plasma adiponectin was measured using a commercially available enzyme-linked immunoassay (ELISA) kit (Daichii ® , Tokyo-Japan). TAOS was determined in one run using colorimetric methods, reagents produced by RANDOX ® (Crumlin, UK). The concentration of CRP was determined using a highsensitivity chemiluminescent assay on the Immulite ® (Dade-Behring, Los Angeles, CA, USA).
Data Analysis
Data analysis was done using SPSS 13.0 statistical analysis software for Windows (SPSS Inc., Chicago, IL, USA). Distributions of continuous variables were assessed for normality using the Kolmogorov-Smirnov. For continuous variables with normal distributions, such as anthropometric and biochemical measures, data were presented as mean ± SD. Statistical analysis was performed using a two-tailed t test for comparison between two groups.
Associations between continuous variables with approximately normal distributions were described using Spearman's correlation coeffi cients. All tests were twosided and considered signifi cant at p < 0.05.
Logistic regression analysis was used to assess OR for the development of MetS. For this purpose, median values of adiponectin, TAOS and hsCRP were dichotomized to assume risk for the development of MetS. Table 1 showed that both non-MetS and MetS subjects had comparable age, smoking habit, height, serum LDL-C and TAOS concentrations. The MetS subjects had higher body weight, BMI, WC, SBP, DBP, triglycerides, and hsCRP than the non-MetS subjects. On the other hand, the MetS subjects had lower HDL-C and adiponectin than their non-MetS counterpats.
RESULTS
Figures 1 demonstrate the association between WC and adiponectin, TAOS, and hsCRP. WC associated negatively with adiponectin concentrations (r s = -0.418; p < 0.01), but associated positively with TAOS (r s = 0.286; p = 0.015) and hsCRP (r s = 0.597; p < 0.01).
Median values of serum adiponectin, TAOS and hsCRP concentrations were used as cut-offs to defi ne risk for the development of MetS. Subjects with serum adiponectin concentrations < 3.47 μg/dL, serum hsCRP concentrations > 1.44 mg/L and adiponectin-hsCRP ratio ≤ 2.31 were considered at risk for MetS. These variables were then included in the logistic regression model. 
DISCUSSION
This study was designed to verify the notion that low grade infl ammation was linked to the development of CVD through MetS, which has been described extensively in the western literatures. IDF has put forward central obesity as the key clinical indicator of MetS. 11 This model is assumed to contribute to the low levels of adiponectin, as an anti-infl ammatory adipokine in MetS, 8 and our fi ndings have confi rmed this notion.
The current study was one, amongst others, describing characteristics of non-MetS and MetS Indonesian men. Studies on MetS using Indonesian ethnic are hardly available. Male subjects were chosen to minimize the variations due to differences in endocrinologic profi les.
Moreover, we applied IDF criteria to defi ne the MetS and challenged the hypothesis that this criteria was comparable, if not better than NCEP-ATP III's or AHA's clinical defi nitions for MetS, as mostly described in many studies. 12, 13 In comparison with the studies done by Devaraj et al 12 and Mojiminiyi et al. 13 using different subjects' entry criteria, the IDF criteria demonstrated its validity for the manifestation of adiponectin and hsCRP concentrations in non-MetS and MetS subjects. However, the ORs of adiponectin, hsCRP, and adiponectin-hsCRP ratio for the development of MetS in Devaraj's study 12 were much lower than those of our study. These fi ndings indicate that the IDF criteria are more relevant to be applied whenever adiponectin and hsCRP are used to predict the occurrence of MetS. IDF criteria affi rmed the inclusion of central obesity as the key clinical indicator to enter the defi nition of MetS. Central obesity is indeed a key determinant of hypoadiponectinemia and low grade infl ammation, as has been shown in our study. Ouchi et al 8 were able to show reciprocal association of CRP and adiponectin in blood stream and adipose tissue.
In contrast to the study of Furukawa et al. 1 , which demonstrated differences in the levels of superoxide dismutase (SOD), glutathione peroxidase (GPX), catalase, peroxidase and lipid F2-Isoprostan (F2IsoPs) between non-MetS and MetS subjects, this study was not able to show differences in the levels of TAOS between the non-MetS and MetS subjects. There are at least 2 arguments to explain this fi nding. Firstly, the measured antioxidants were less specifi c. The measurement of TAOS was based on the capacity of biological fl uids to inhibit the production of thiobarbituric acid reactive substance (TBARS) from sodium benzoate which is infl uenced by the free radicals generated by Fenton reaction of the reagent used.
14,15 Furthermore, within the serum specimens, there are constituents of uric acid, pyruvate and albumin, which can increase the capacity of TAOS. Arginine, cysteine, tryptophan and reduced glutathione (GSH) are also considered as weak antioxidants. 15, 16 Those serum constituents were not measured in the current study. Secondly, the TAOS variable has signifi cant limitations that it is a measure of serum antioxidant and may not refl ect the state of intracellular antioxidants, or targeted areas of stress, such as oxidative stress on endothelial cells or vascular smooth muscle cells as the target of atherogenesis process. 17 Verma et al. 7 suggested a notion that CRP was a circulating biomarker of endothelial dysfunction. This notion was based on the fact that human recombinant CRP, at the concentrations known to predict vascular disease, elicited a multitude of effects on endothelial biology favoring a pro-infl ammatory and proatherosclerotic phenotype. 7, 18 Findings of this study indicated the high OR value for subjects with serum hsCRP concentrations of higher than median to develop MetS. This specifi c fi nding has led to a speculation that subjects with MetS who participated in this study had developed endothelial dysfunction.
In conclusions, the use of adiponectin-hsCRP ratio increases the predictive power for the occurrence of MetS by 4-6 times the predictive power of adiponectin or hsCRP alone. Our study was able to demonstrate that in Indonesian men, IDF criteria is recommended to be applied adiponectin and hsCRP are used to predict the occurrence of MetS.
